Résumé
En 1982, Mulliken et Glowacki [1] ont proposé une classification biologique des lésions vasculaires des parties molles. Cette classification a été redéfinie en 1996 lors de l’ISSVA (International Society for the Study of Vascular Anomalies) par Enjolras et Mulliken qui distinguent les hémangiomes des malformations vasculaires (à flux lent ou à flux rapide) selon leurs caractéristiques cliniques biologiques, hémodynamiques et histopathologiques.
Preview
Unable to display preview. Download preview PDF.
Références
Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69: 412–20
Mazoyer E, Enjolras O, Bisdorff A et al. (2008). Coagulation disorders in patients with venous malformations of the limbs and trunk. A case series of 118 patients. Arch Dermatol 144:861–7
Burrows PE, Mason KP (2004) Percutaneous treatment of low flow vascular malformations, Vasc Interv Radiol 431–45
Bisdorff A, Mazighi M, Saint Maurice JP et al. (2011) Ethanol threshold dosis for systemic complications during sclerotherapy of superficial venous malformations: a retrospective study. Neuroradiology 53: 891–4
Gulsen F, Cantasdemir M, Solak S, et al. (2011) Percutaneou sclerotherapy of peripheral venous malformations in pediatric patients. Pediatr Surg Int 27: 1283–7
Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P (2003) Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 139: 1409–16
Spence J, Krings T, Terbrugge KG et al. (2010) Percutaneous Sclerotherapy for facial venous malformations: Subjective clinical and objective MR Imaging follow-up results. AJNR 31: 955–60
Spence J, Krings T, Terbrugge KG, Agid R (2011) Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head and Neck 33: 125–30
Dompmartin A, Blaizot X, Theron J et al. (2011) Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol 21: 2647–56
Min RJ, Khilnani N, Zimmet SE (2003) Endovenous laser treatment of saphenous vein reflux: long term results. J Vasc Interv Radiol 14: 991–96
Sidhu MK, Perkins JA, Shaw DW et al. (2005) Ultrasoundguided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol 16: 879–84
Lee BB, Bergan JJ (2002) Advanced management of congenital vascular malformations: a multidisciplinary approach. Cardiovasc Surg 10: 523–33
M. Vikkula (2006) Pathogénie et génétique des anomalies vasculaires. Pathogenesis and genetics of vascular anomalies Annales de chirurgie plastique esthétique 51: 282–86
Rautio R, Saarinen J, Laranne J, Salenius JP et al. (2004) Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment. Acta Radiol 45: 397–403
Li L, Zeng XQ, Li YH (2010) Digital subtraction angiographyguided foam sclerotherapy of peripheral venous malformations. AJR Am J Roentgenol 194: W439–44
Van der Linden E, Pattynama PM, Heeres BC et al. (2009) Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations. Radiology 251: 926–32
Goyal M, Causer PA, Armstrong D (2002) Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology 223: 639–44
Dubois J, Soulez G, Oliva VL et al. (2001) Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics 21: 1519–31
Yun WS, Kim YW, Lee KB et al. (2009) Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg 50: 581–9
Lee BB, Kim DI, Huh S, et al. 2001) New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg 33: 764–72
Hakes WF, Hass DK, Parker SH (1993) Symptomatic vascular malformations: ethanol embolotherapy. Radiology 170: 1059–66
Yakes WF, Baker R (1993) Cardioplulmonary collapse: sequelae of ethanol embolotherapy. Radiology 189:145
Baud AV, Breton P, Guibaud L, Freidel M (2000) Treatment of low-pressure vascular malformations by injection of Ethibloc. Study of 19 cases and analysis of complications. Rev Stomatol Chir Maxillofac 101: 181–8
Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26: 323–8
Berenguer B, Burrows PE, Zurakowski D et al. (1999) Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 104: 1–11; discussion 12–5
Tessari L, Cavezzi A, Frullini A (2001) Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27: 58–60
Breu FX, Guggenbichler S, Wollmann JC (2008) 2nd European Consensus Meeting on Foam Sclerotherapy. Vasa 37 Suppl 71: 1–29
Hsu TS, Weiss RA (2003) Foam sclerotherapy: a new era. Arch Dermatol 139: 1494–6
Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P (2003) Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 139: 1409–16
Pascarella L, Bergan JJ, Yamada C, Mekenas L (2005) Venous angiomata: treatment with sclerosant foam. Ann Vasc Surg 19: 457–64
Ceulen RP, Sommer A, Vernooy K (2008) Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 358: 1525–6
Yamaki T, Nozaki M, Sakurai H et al. (2008) Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 47: 578–84
Ceulen RP, Sommer A, Vernooy K (2008) Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 358: 1525–6
Yamaki T, Nozaki M, Sakurai H et al. (2009) Multiple Small-Dose Injections Can Reduce the Passage of Sclerosant Foam into Deep Veins During Foam Sclerotherapy for Varicose Veins. Eur J Vasc Endovasc Surg 37: 343–8
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Bisdorff-Bresson, A., Laurian, C., Vernhet-Kovacsik, H. (2013). Traitement endovasculaire des malformations veineuses périphériques. In: Thérapeutiques endovasculaires des pathologies veineuses. Springer, Paris. https://doi.org/10.1007/978-2-8178-0291-6_18
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0291-6_18
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0290-9
Online ISBN: 978-2-8178-0291-6
eBook Packages: MedicineMedicine (R0)